BioPharm America™ 2015 plays an essential role in forging vital partnerships across the life science ecosystem for the benefit of each player, and the industry at large. The strength of a cluster can leverage the expertise of industry leaders with a critical mass of knowledge and innovation available in a concentrated hub like Boston.
Boston is an ideal biotech hub for forging alliances among the ecosystem for many reasons, including:
- The life sciences corridor in Massachusetts combines the cities of Somerville, Cambridge, Boston, Quincy and Braintree, and is home to over 450 companies within the life science industry cluster.
- There were USD 1,802 billion of venture investments in Massachusetts biotechs in 2014.
- Massachusetts has seen 30 companies go public in the last two years.
- Some of the largest biopharmaceutical companies in the world have a presence in the life sciences corridor, including Biogen, Boston Scientific, GlaxoSmithKline, Johnson & Johnson Innovation Center, Merck & Co., Novartis, Pfizer, Sanofi, Vertex Pharmaceuticals, and more.
Find more reasons in Spotlight on Boston. There won’t be a better time this year to engage with the rich life science ecosystem than this September 15–17. Register now to plan your Boston week at BioPharm America.